Literature DB >> 19546585

Impact of residual renal function on plasma levels of advanced oxidation protein products and pentosidine in peritoneal dialysis patients.

Ryuichi Furuya1, Hiromichi Kumagai, Mari Odamaki, Masaaki Takahashi, Asumi Miyaki, Akira Hishida.   

Abstract

BACKGROUND: Residual renal function (RRF) affects the survival rate and the development of cardiovascular disease in peritoneal dialysis (PD) patients. We evaluated the impact of RRF on oxidative and carbonyl stress in PD patients.
METHODS: Plasma advanced oxidation protein products (AOPP) and pentosidine were measured in PD patients with a urine volume of > or =300 ml/day (group A, n = 17) and <300 ml/day (group B, n = 14). AOPP and pentosidine were reevaluated after 12 months of follow-up in group A.
RESULTS: Plasma levels of AOPP and pentosidine in group A were significantly lower than those in group B. Renal creatinine clearance was inversely correlated with AOPP (p < 0.05) and pentosidine (p < 0.01). After 12 months of follow-up, no significant change was observed in AOPP and pentosidine in groups who maintained a urine volume of > or =300 ml/day, but significantly increased in groups whose urine volume decreased to less than 300 ml/day. There were significant inverse relationships between the changes in renal creatinine clearance and AOPP (p < 0.01) and pentosidine (p < 0.05).
CONCLUSION: Loss of RRF is associated with increased plasma AOPP and pentosidine, indicating that preservation of RRF has a beneficial effect in reducing the oxidative and carbonyl stress in PD patients. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19546585     DOI: 10.1159/000224792

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  15 in total

1.  Gastrointestinal symptoms in patients undergoing peritoneal dialysis: multivariate analysis of correlated factors.

Authors:  Rui Dong; Zhi-Yong Guo
Journal:  World J Gastroenterol       Date:  2010-06-14       Impact factor: 5.742

2.  Effluent free radicals are associated with residual renal function and predict technique failure in peritoneal dialysis patients.

Authors:  Hiroshi Morinaga; Hitoshi Sugiyama; Tatsuyuki Inoue; Keiichi Takiue; Yoko Kikumoto; Masashi Kitagawa; Shigeru Akagi; Kazushi Nakao; Yohei Maeshima; Ikuko Miyazaki; Masato Asanuma; Makoto Hiramatsu; Hirofumi Makino
Journal:  Perit Dial Int       Date:  2012-01-03       Impact factor: 1.756

3.  Involvement of oxidative stress in the relapse of acute myeloid leukemia.

Authors:  Fu-Ling Zhou; Wang-Gang Zhang; Yong-Chang Wei; Shan Meng; Gai-Gai Bai; Bai-Yan Wang; Hui-Yun Yang; Wei Tian; Xin Meng; Hui Zhang; She-Ping Chen
Journal:  J Biol Chem       Date:  2010-03-16       Impact factor: 5.157

Review 4.  Cardiovascular risk in the peritoneal dialysis patient.

Authors:  Raymond T Krediet; Olga Balafa
Journal:  Nat Rev Nephrol       Date:  2010-06-22       Impact factor: 28.314

5.  Assessment of the effect of perineural dexmedetomidine on oxidative stress during peritoneal dialysis catheter insertion: a randomized, controlled trial.

Authors:  Xiaoli Zhang; Guangsen Liu; Cong Sun; Yi Zhong; Ling Wang; Zhihua Huang; Guoping Wang; Reai Shan
Journal:  Int Urol Nephrol       Date:  2022-06-30       Impact factor: 2.370

6.  Oxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients.

Authors:  Hong Xu; Makoto Watanabe; Abdul Rashid Qureshi; Olof Heimbürger; Peter Bárány; Björn Anderstam; Monica Eriksson; Peter Stenvinkel; Bengt Lindholm
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

7.  Pentosidine levels in nonproteinuric diabetes associated with both low estimated glomerular filtration rate and cataract.

Authors:  Xiu-Li Lim; Boon-Wee Teo; Bee-Choo Tai; Tien Y Wong; Daniel P-K Ng
Journal:  Diabetes Metab Syndr Obes       Date:  2012-06-29       Impact factor: 3.168

8.  Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.

Authors:  Anna Machowska; Jia Sun; Abdul Rashid Qureshi; Naohito Isoyama; Paul Leurs; Björn Anderstam; Olof Heimburger; Peter Barany; Peter Stenvinkel; Bengt Lindholm
Journal:  PLoS One       Date:  2016-10-04       Impact factor: 3.240

9.  The Relationship between Advanced Oxidation Protein Products, Vascular Calcifications and Arterial Stiffness in Predialysis Chronic Kidney Disease Patients.

Authors:  Ion-Vlad Vinereanu; Ileana Peride; Andrei Niculae; Andreea Taisia Tiron; Andra Caragheorgheopol; Dana Manda; Ionel Alexandru Checherita
Journal:  Medicina (Kaunas)       Date:  2021-05-06       Impact factor: 2.430

10.  An Increase of Plasma Advanced Oxidation Protein Products Levels Is Associated with Cardiovascular Risk in Incident Peritoneal Dialysis Patients: A Pilot Study.

Authors:  Elena Gonzalez; Maria-Auxiliadora Bajo; Juan J Carrero; Bengt Lindholm; Cristina Grande; Rafael Sánchez-Villanueva; Gloria Del Peso; Mariana Díaz-Almirón; Pedro Iglesias; Juan J Díez; Rafael Selgas
Journal:  Oxid Med Cell Longev       Date:  2015-10-25       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.